Skip to content

Planned Semi-Elective Lung Tx Study

Planned Semi-Elective Lung Transplantation Using 10C Cold Static Preservation: A Proof-Of-Concept Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04601818
Enrollment
45
Registered
2020-10-26
Start date
2020-11-30
Completion date
2024-09-05
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Transplant, To Compare Lung Transplant Outcomes Between Study Patients and Standard Patients Who Have Already Undergone Lung Transplantation by Conventional Procedures

Brief summary

When suitable donor lungs become available for a consented recipient, and the donor cross clamp time occurs between 6pm and 4am, the transplant procedure (anesthesia starting time) will be allowed to be moved to a 6am start or later with the lungs being preserved at 10C cold static preservation upon organ arrival to our hospital using a specific refrigerator. The maximum allowed time between donor cross clamp and recipient anesthesia initiation will be 12h.

Interventions

PROCEDUREExperimental: Preserving of Donor Lungs

lung transplants that have a proposed after hours start time will be delayed until 6am and the donor lungs will be preserved for no more than 12 hours at 10 degrees celsius cold static

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Primary lung transplantation * Informed consent provided Donor Inclusion: Age\<70

Exclusion criteria

* Re-transplantation * Multi-organ transplantation Donor

Design outcomes

Primary

MeasureTime frame
Incidence of ISHLT Primary Graft Dysfunction Grade 3 at 72 hours (expected rate less than 20%)72 hours post op

Secondary

MeasureTime frame
1-year survivalprocedure up to 1 year post op

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMindaugas Rackauskas, MD, PhD

University of Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026